{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:10:42Z","timestamp":1793373042961,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejps.2021.106103","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T03:41:10Z","timestamp":1639971670000},"page":"106103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":524,"special_numbering":"C","title":["Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome"],"prefix":"10.1016","volume":"170","author":[{"given":"Thiruchelvi","family":"Pulingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaigarajan","family":"Parumasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirah Mohd","family":"Gazzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlinah Mohd","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun Yee","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai Fung","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sudesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.106103_bib0001","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2666-5247(21)00039-2","article-title":"COVID-19 drug practices risk antimicrobial resistance evolution","volume":"2","author":"Afshinnekoo","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ejps.2021.106103_bib0002","article-title":"Averting the AMR crisis: what are the avenues for policy action for countries in Europe?","author":"Anderson","year":"2019","journal-title":"Eur. Observatory Health Syst. Polic."},{"key":"10.1016\/j.ejps.2021.106103_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001165","article-title":"Conjugative DNA transfer induces the bacterial SOS response and promotes antibiotic resistance development through integron activation","volume":"6","author":"Baharoglu","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejps.2021.106103_bib0004","series-title":"Drug-resistant infections: A threat to Our Economic Future","author":"Bank","year":"2017"},{"key":"10.1016\/j.ejps.2021.106103_bib0005","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/cid\/cit070","article-title":"Seven ways to preserve the miracle of antibiotics","volume":"56","author":"Bartlett","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2021.106103_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4065603","article-title":"Multidrug resistant and extensively drug resistant bacteria: a study","volume":"2016","author":"Basak","year":"2016","journal-title":"J. Pathog."},{"key":"10.1016\/j.ejps.2021.106103_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/CMR.00059-12","article-title":"Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?","volume":"26","author":"Beceiro","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.106103_bib0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12866-017-0994-6","article-title":"In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)","volume":"17","author":"Bitrus","year":"2017","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000518","article-title":"Antimicrobial resistance and universal health coverage","volume":"2","author":"Bloom","year":"2017","journal-title":"BMJ Glob.Health"},{"key":"10.1016\/j.ejps.2021.106103_bib0011","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-2600(18)30271-6","article-title":"Superbugs: an arms race against bacteria","volume":"6","author":"Burki","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0012","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3181\/00379727-51-13986","article-title":"Resistance of Staphylococcus aureus to the action of penicillin","volume":"51","author":"Charles","year":"1942","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0013","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","article-title":"Alternatives to antibiotics \u2013 a pipeline portfolio review","volume":"16","author":"Czaplewski","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"00113891","key":"10.1016\/j.ejps.2021.106103_bib0014","first-page":"923","article-title":"Studies on mutations in embB locus in Indian clinical isolates of Mycobacterium tuberculosis having high degree of ethambutol resistance","volume":"91","author":"Das","year":"2006","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.8153624","article-title":"Inactivation of antibiotics and the dissemination of resistance genes","volume":"264","author":"Davies","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejps.2021.106103_bib0016","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejps.2021.106103_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0018","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ije\/dys046","article-title":"Status of epidemiology in the WHO south-east Asia region: burden of disease, determinants of health and epidemiological research, workforce and training capacity","volume":"41","author":"Dhillon","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0019","first-page":"11","article-title":"Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects","volume":"46","author":"D\u017eidi\u0107","year":"2008","journal-title":"Food Technol. Biotechnol."},{"key":"10.1016\/j.ejps.2021.106103_bib0020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejps.2021.106103_bib0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fmicb.2020.00103","article-title":"Resistance evolution against antimicrobial peptides in Staphylococcus aureus alters pharmacodynamics beyond the MIC","volume":"11","author":"El Shazely","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0022","series-title":"Antimicrobial Drug resistance: Mechanisms of Drug Resistance","first-page":"37","article-title":"Pharmacology of drug resistance","author":"Elizabth","year":"2017"},{"key":"10.1016\/j.ejps.2021.106103_bib0023","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1471-4892(03)00109-7","article-title":"The evolution of a resistant pathogen \u2013 the case of MRSA","volume":"3","author":"Enright","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106103_bib0024","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dnp.2009.22.4.1367708","article-title":"SASP gene delivery: a novel antibacterial approach","volume":"22","author":"Fairhead","year":"2009","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejps.2021.106103_bib0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1473-3099(01)00020-2","article-title":"Can antibiotic-resistant nosocomial infections be controlled?","volume":"1","author":"Farr","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2021.106103_bib0026","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fern\u00e1ndez","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.106103_bib0027","doi-asserted-by":"crossref","first-page":"e18127","DOI":"10.1371\/journal.pone.0018127","article-title":"Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against Gram-positive pathogenic bacteria","volume":"6","author":"Fiamegos","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2021.106103_bib0028","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0029","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/embor.2008.110","article-title":"Pricing infectious disease: the economic and health implications of infectious diseases","volume":"9","author":"Fonkwo","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejps.2021.106103_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1179\/1973947812Y.0000000015","article-title":"Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece","volume":"24","author":"Galani","year":"2012","journal-title":"J. Chemother."},{"key":"10.1016\/j.ejps.2021.106103_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C5MD00344J","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejps.2021.106103_bib0032","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2471\/BLT.20.268573","article-title":"Tackling antimicrobial resistance in the COVID-19 pandemic","volume":"98","author":"Getahun","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ejps.2021.106103_bib0033","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/medicina47030019","article-title":"Antibiotic resistance mechanisms of clinically important bacteria","volume":"47","author":"Giedraitien\u0117","year":"2011","journal-title":"Medicina"},{"key":"10.1016\/j.ejps.2021.106103_bib0034","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.106103_bib0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to rifampicin: a review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejps.2021.106103_bib0036","article-title":"Are antibiotics turning livestock into superbug factories","author":"Guglielmi","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejps.2021.106103_bib0037","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1534\/genetics.110.124628","article-title":"The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase","volume":"187","author":"Hall","year":"2011","journal-title":"Genetics"},{"key":"10.1016\/j.ejps.2021.106103_bib0038","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fmicb.2014.00288","article-title":"Benefits and risks of antimicrobial use in food-producing animals","volume":"5","author":"Hao","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0039","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/jb.158.2.513-516.1984","article-title":"Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus","volume":"158","author":"Hartman","year":"1984","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejps.2021.106103_bib0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3349\/ymj.1998.39.6.526","article-title":"Acquisition of methicillin resistance and progression of multiantibiotic resistance in methicillin-resistant Staphylococcus aureus","volume":"39","author":"Ito","year":"1998","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.ejps.2021.106103_bib0041","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021105","article-title":"The mycobacterial cell envelope\u2014Lipids","volume":"4","author":"Jackson","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0042","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7150\/ijbs.4.338","article-title":"Inducible SOS response system of DNA repair and mutagenesis in Escherichia coli","volume":"4","author":"Janion","year":"2008","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0043","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-6968.1994.tb07194.x","article-title":"Mycobacterial cell wall: structure and role in natural resistance to antibiotics","volume":"123","author":"Jarlier","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejps.2021.106103_bib0044","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-2836(88)90517-7","article-title":"Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance","volume":"202","author":"Jin","year":"1988","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejps.2021.106103_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0046","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5808\/GI.2014.12.4.276","article-title":"Understanding rifampicin resistance in tuberculosis through a computational approach","volume":"12","author":"Kumar","year":"2014","journal-title":"Genom. Inform."},{"key":"10.1016\/j.ejps.2021.106103_bib0047","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4155\/fmc.13.80","article-title":"Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections","volume":"5","author":"Labby","year":"2013","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.ejps.2021.106103_bib0048","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/ijerph10094274","article-title":"Strategies to minimize antibiotic resistance","volume":"10","author":"Lee","year":"2013","journal-title":"Int. J. of Environ. Res. Public Health"},{"key":"10.1016\/j.ejps.2021.106103_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.vas.2019.100058","article-title":"Patterns of antibiotic use in global pig production: a systematic review","volume":"7","author":"Lekagul","year":"2019","journal-title":"Vet. Anim. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0050","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/AAC.06064-11","article-title":"In vitro antibacterial activity of the ceftazidime-avibactam (nxl104) combination against Pseudomonas aeruginosa clinical isolates","volume":"56","author":"Levasseur","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.106103_bib0051","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0052","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/485439a","article-title":"Antibiotics: recover the lost art of drug discovery","volume":"485","author":"Lewis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2021.106103_bib0053","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2165\/11317030-000000000-00000","article-title":"Efflux-mediated drug resistance in bacteria: an update","volume":"69","author":"Li","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2021.106103_bib0054","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.106103_bib0055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.106103_bib0056","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab052","article-title":"Antibiotic resistance during and beyond COVID-19","volume":"3","author":"Livermore","year":"2021","journal-title":"JAC Antimicrob. Resistance"},{"key":"10.1016\/j.ejps.2021.106103_bib0057","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2021.106103_bib0058","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejps.2021.106103_bib0059","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00018-010-0389-4","article-title":"Mobile genetic elements of Staphylococcus aureus","volume":"67","author":"Malachowa","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","article-title":"Antibacterial peptides for therapeutic use: obstacles and realistic outlook","volume":"6","author":"Marr","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106103_bib0061","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.120161797","article-title":"The SOS response regulates adaptive mutation","volume":"97","author":"McKenzie","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0062","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/diagnostics5020200","article-title":"Diagnostics for developing countries","volume":"5","author":"McNerney","year":"2015","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejps.2021.106103_bib0063","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/eva.12196","article-title":"The fitness costs of antibiotic resistance mutations","volume":"8","author":"Melnyk","year":"2015","journal-title":"Evolut. Appl."},{"key":"10.1016\/j.ejps.2021.106103_bib0064","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of Antibiotic Resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.ejps.2021.106103_bib0065","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/jac\/dkq306","article-title":"In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters","volume":"65","author":"Mushtaq","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2021.106103_bib0066","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/1040841X.2020.1813687","article-title":"Antimicrobial resistance: more than 70 years of war between humans and bacteria","volume":"46","author":"Nadeem","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0067","first-page":"1","article-title":"Estimating the burden of antimicrobial resistance: a systematic literature review","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrob. Resistance Infect.n Control"},{"key":"10.1016\/j.ejps.2021.106103_bib0068","first-page":"1","article-title":"Antimicrobial resistance: tackling a crisis for the health and wealth of nations","volume":"20","author":"O'neill","year":"2014","journal-title":"Rev. Antimicrob. Resistance"},{"key":"10.1016\/j.ejps.2021.106103_bib0069","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/AAC.40.4.1053","article-title":"Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan","volume":"40","author":"Ohno","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.106103_bib0070","doi-asserted-by":"crossref","first-page":"E5052","DOI":"10.1073\/pnas.1704125114","article-title":"Peripheral modifications of [\u03a8[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics","volume":"114","author":"Okano","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0071","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection","volume":"288","author":"Oliver","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejps.2021.106103_bib0072","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1469-0691.2010.03250.x","article-title":"Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance","volume":"16","author":"Oliver","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejps.2021.106103_bib0073","first-page":"43","article-title":"Effects of a lipophilic isoniazid derivative on the growth and cellular morphogenesis of Mycobacterium tuberculosis H37Rv","volume":"5","author":"Parumasivam","year":"2013","journal-title":"Int. J. Pharm. Pharma. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0074","first-page":"313","article-title":"Anti-tuberculosis activity of lipophilic isoniazid derivatives and their interactions with first-line anti-tuberculosis drugs","volume":"7","author":"Parumasivam","year":"2013","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ejps.2021.106103_bib0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jama.281.4.361","article-title":"Access to essential drugs in poor countries: a lost battle?","volume":"281","author":"P\u00e9coul","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2021.106103_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105087","article-title":"Synergistic antibacterial actions of graphene oxide and antibiotics towards bacteria and the toxicological effects of graphene oxide on human epidermal keratinocytes","volume":"142","author":"Pulingam","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0077","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/549302","article-title":"Production of Pseudomonas aeruginosa intercellular small signaling molecules in human burn wounds","volume":"2011","author":"Que","year":"2011","journal-title":"J. Pathog."},{"key":"10.1016\/j.ejps.2021.106103_bib0078","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.44.2.326-336.2000","article-title":"Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis","volume":"44","author":"Ramaswamy","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.106103_bib0079","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid0402.980207","article-title":"Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives","volume":"4","author":"Rattan","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejps.2021.106103_bib0080","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/JB.181.3.1043-1044.1999","article-title":"Escherichia coli cells exposed to streptomycin display a mutator phenotype","volume":"181","author":"Ren","year":"1999","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejps.2021.106103_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003775","article-title":"Understanding and overcoming antibiotic resistance","volume":"15","author":"Richardson","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejps.2021.106103_bib0082","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2148-13-50","article-title":"Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress","volume":"13","author":"Rodr\u00edguez-Verdugo","year":"2013","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.ejps.2021.106103_bib0083","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/S1473-3099(19)30552-3","article-title":"Inter) nationalising the antibiotic research and development pipeline","volume":"20","author":"Singer","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2021.106103_bib0084","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.0602138103","article-title":"Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients","volume":"103","author":"Smith","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/rr54","article-title":"The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis","volume":"2","author":"Somoskovi","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejps.2021.106103_bib0086","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4161\/viru.23724","article-title":"Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm","volume":"4","author":"Soto","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.ejps.2021.106103_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-018-0620-2","article-title":"The role of environmental contamination in the transmission of nosocomial pathogens and healthcare-associated infections","volume":"20","author":"Suleyman","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ejps.2021.106103_bib0088","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5530\/jppcm.2017.4.62","article-title":"Inappropriate antibiotic utilization: outpatient prescription review of a regional secondary hospital in Kedah, Malaysia","volume":"3","author":"Tan","year":"2017","journal-title":"J. Pharm. Pract. Commun. Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0089","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1289\/ehp.1104650","article-title":"Selective pressure of antibiotic pollution on bacteria of importance to public health","volume":"120","author":"Tello","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejps.2021.106103_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12703\/P5-51","article-title":"New and alternative approaches to tackling antibiotic resistance","volume":"5","author":"Tillotson","year":"2013","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.ejps.2021.106103_bib0091","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/JB.185.11.3469-3472.2003","article-title":"Error-prone polymerase, DNA Polymerase IV, is responsible for transient hypermutation during adaptive mutation in Escherichia coli","volume":"185","author":"Tompkins","year":"2003","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejps.2021.106103_bib0092","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1073\/pnas.1503141112","article-title":"Global trends in antimicrobial use in food animals","volume":"112","author":"Van Boeckel","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0093","first-page":"285","article-title":"Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera","volume":"138","author":"Varela","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejps.2021.106103_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2013.06.010","article-title":"PK\/PD models in antibacterial development","volume":"16","author":"Velkov","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0095","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.ejps.2021.106103_bib0096","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1073\/pnas.0507407103","article-title":"Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes","volume":"103","author":"Ventre","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2021.106103_bib0097","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000231","article-title":"Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia infectious disease clinical research network (SEAICRN)","volume":"7","author":"Wertheim","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejps.2021.106103_bib0098","series-title":"Antimicrobial Resistance: Global Report on Surveillance","year":"2014"},{"key":"10.1016\/j.ejps.2021.106103_bib0099","unstructured":"WHO, 2021. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021."},{"key":"10.1016\/j.ejps.2021.106103_bib0100","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/JCM.40.11.3970-3975.2002","article-title":"mecA gene is widely disseminated in Staphylococcus aureus population","volume":"40","author":"Wielders","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejps.2021.106103_bib0101","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multi-drug resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejps.2021.106103_bib0102","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics: enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.106103_bib0103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1741-7007-8-123","article-title":"Q&A: antibiotic resistance: where does it come from and what can we do about it?","volume":"8","author":"Wright","year":"2010","journal-title":"BMC Biol."},{"key":"10.1016\/j.ejps.2021.106103_bib0104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9459(24)07757-X","article-title":"The pharmacology of HIV drug resistance","volume":"70","author":"Zdanowicz","year":"2006","journal-title":"Am. J. Pharm. Educ."},{"key":"10.1016\/j.ejps.2021.106103_bib0105","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/AAC.04933-14","article-title":"Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates from China","volume":"59","author":"Zhao","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721004048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721004048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:00:42Z","timestamp":1760529642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721004048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":105,"alternative-id":["S0928098721004048"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.106103","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.106103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106103"}}